During the past decade, Retina Vitreous Consultants conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 10 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Vitreous Consultants" #1 sponsor was "Jaeb Center for Health Research" with 7 trials, followed by "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Genaera Corporation" with 1 trials sponsored and "National Eye Institute (NEI)" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Vitreous Consultants" #1 collaborator was "National Eye Institute (NEI)" with 7 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Retina Vitreous Consultants" are "Diabetic Macular Edema" (5 trials), "Geographic Atrophy" (3 trials), "Diabetic Retinopathy" (2 trials), "Proliferative Diabetic Retinopathy" (2 trials) and ""Wet" Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Retina Vitreous Consultants" in a lesser frequency.

Most popular intervention types in "Retina Vitreous Consultants" are "Drug" (17 trials), "Other" (4 trials), "Procedure" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deferred aflibercept" (2 trials), "Deferred laser" (2 trials), "Lampalizumab" (2 trials), "Placebo" (2 trials) and "Prompt aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Vitreous Consultants" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Retina Vitreous Consultants". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Retina Vitreous Consultants, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Vitreous Consultants, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".